Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_assertion type Assertion NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_head.
- NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_assertion wasGeneratedBy ECO_0000203 NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_provenance.
- NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_assertion wasDerivedFrom befree-20140225 NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_provenance.
- NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_assertion SIO_000772 20595063 NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_provenance.
- NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_assertion evidence source_evidence_literature NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_provenance.
- NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482605.RAGaQAejyhzxU9D0c1nPSSnCRWwrnf4XA49qkMPbYd1C4130_provenance.